Correlation Between Viracta Therapeutics and Eyenovia
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Eyenovia, you can compare the effects of market volatilities on Viracta Therapeutics and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Eyenovia.
Diversification Opportunities for Viracta Therapeutics and Eyenovia
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viracta and Eyenovia is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Eyenovia go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Eyenovia
Given the investment horizon of 90 days Viracta Therapeutics is expected to generate 0.26 times more return on investment than Eyenovia. However, Viracta Therapeutics is 3.85 times less risky than Eyenovia. It trades about -0.43 of its potential returns per unit of risk. Eyenovia is currently generating about -0.24 per unit of risk. If you would invest 24.00 in Viracta Therapeutics on August 24, 2024 and sell it today you would lose (9.00) from holding Viracta Therapeutics or give up 37.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viracta Therapeutics vs. Eyenovia
Performance |
| Timeline |
| Viracta Therapeutics |
| Eyenovia |
Viracta Therapeutics and Eyenovia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Eyenovia
The main advantage of trading using opposite Viracta Therapeutics and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
| Eyenovia vs. Reviva Pharmaceuticals Holdings | Eyenovia vs. Cidara Therapeutics | Eyenovia vs. Fortress Biotech | Eyenovia vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |